In a research report released today, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Receptos Inc (NASDAQ:RCPT), after the biopharma company released its second-quarter results, …
Celgene Corporation (NASDAQ:CELG) announced that its direct wholly-owned subsidiary, Strix Corporation, has commenced its previously announced tender offer for all outstanding shares of …
Healthcare investors can sleep easy tonight with one of 2015’s major unanswered questions now off the table. Celgene Corporation (NASDAQ:CELG) will buy Receptos …
Celgene Corporation (NASDAQ:CELG)’s proposed $7.2 billion acquisition of Receptos Inc (NASDAQ:RCPT) would bring the pharmaceutical giant a potential blockbuster product candidate, Ozanimod, currently in Phase 3 development for the …
Cantor analyst Mara Goldstein weighed in today with her views on the acquisition of Receptos Inc (NASDAQ:RCPT) by Celgene Corporation (NASDAQ:CELG) that was announced yesterday after-market close. …
Receptos Inc (NASDAQ:RCPT) shares rose 10 per cent in after-hours trading, following the news that Celgene Corporation (NASDAQ:CELG) intends to acquire Receptos for $232/share or $7.2 billion net …
Celgene Corporation (NASDAQ:CELG) and Receptos Inc (NASDAQ:RCPT) announced the signing of a definitive agreement in which Celgene has agreed to acquire Receptos. Under the …
Last week, Liana Moussatos of Wedbush released a report highlighting a list of upcoming catalysts for biopharmaceutical companies. Specifically, she noted forthcoming events …
Recently, various executives have taken part in insider selling activity for the stocks of Bank of America Corp (NYSE:BAC), QUALCOMM, Inc. (NASDAQ:QCOM), Celldex Therapeutics, …
Wedbush analyst Liana Moussatos has high hopes for Receptos Inc (NASDAQ:RCPT), reiterating an Outperform rating on the stock, while increasing the company’s acquisition value to $348 (from $211). …
